Divis Laboratories Ltd | DIVI - Assets

Stock Price
6,760.50
Daily Change
-161.00 -2.33%
Monthly
7.42%
Yearly
7.66%
Q2 Forecast
6,615.83

Divis Laboratories Ltd reported INR181.51B in Assets for its fiscal quarter ending in September of 2025.





Assets Change Date
Alaunos Therapeutics USD 1.88M 1.08M Mar/2026
Aurobindo Pharma INR 525.46B 27.61B Sep/2025
Avita Medical AUD 56.39M 1.74M Dec/2025
Dianthus Therapeutics USD 1.25B 715.96M Mar/2026
Divis Laboratories Ltd INR 181.51B 12.19B Sep/2025
Ionis Pharmaceuticals USD 3.45B 74M Mar/2026
IQVIA Holdings USD 29.68B 269M Mar/2026
Lupin INR 383.65B 48.64B Mar/2026
Moderna USD 11.49B 850M Mar/2026
Organon & Co USD 13B 129M Mar/2026
Revvity USD 12B 171.82M Mar/2026
Tectonic Therapeutic USD 246.58M 14.46M Mar/2026
Tilray USD 2.1B 15.95M Sep/2025
Viatris USD 36.83B 358.5M Mar/2026
Xeris Pharmaceuticals USD 392.01M 8.49M Mar/2026